- Bruce Stillman, Cold Spring Harbor Laboratory
- Marc Tessier-LaVigne, The Rockefeller University
- Afia Asamoah, Covington & Burling
- Zafrira Avnur, PhD, Roche Partnering
- Glenn Batchelder, Civitas Therapeutics
- Karen Bernstein, PhD, BioCentury Publications
- Joshua H. Bilenker, MD, Aisling Capital
- Laurence Blumberg, MD, Kadmon Corporation
- Anthony Caggiano, MD, PhD, Acorda Therapeutics
- Pamela Carroll, PhD, Janssen/JNJ Innovation Center
- Stephen Chang, PhD, New York Stem Cell Foundation
- Sohini Chowdhury, The Michael J. Fox Foundation for Parkinson’s Research
- Ron Cohen, MD, Acorda Therapeutics, Inc.
- Timothy Coetzee, PhD, National Multiple Sclerosis Society
- Ellen B. Corenswet, Covington & Burling
- Mark Day, PhD, Bristol-Myers Squibb Company
- Pamela R. Demain, MBA, Merck
- Eric Elenko, PhD, PureTech Ventures
- Howard M. Fillit, MD, Alzheimer’s Drug Discovery Foundation
- Vincent Fishchetti, PhD, The Rockefeller University
- James Foley, PhD, AQUA Partners
- Steven C. Gilman, PhD, Cubist Pharmaceuticals
- Julia P. Gregory, ContraFect
|
- Baruch Harris, PhD, Enlight Biosciences
- Cláudia Hirawat, PTC Therapeutics
- Nancy J. Kelley, JD, MPP, New York Genome Center
- Avi Kometz, MD, Ascent Biomedical Ventures
- Jonathan S. Leff, Warburg Pincus
- Jonathan Lewis, MD, PhD, ZIOPHARM Oncology
- Yung S. Lie, PhD, Damon Runyon Cancer Research Foundation
- Gail K. Naughton, PhD, Histogen
- Ronald Newbold, PhD, Pfizer
- Larry Norton, MD, Memorial Sloan-Kettering Cancer Center
- William S. Podd, Landmark Angels
- Rajesh Ranganathan, PhD, National Institutes of Health
- Charles Ryan, JD, PhD, Forest Laboratories, Inc.
- John Ryan, PhD, MD, Kadmon Corporation
- Mark J.Simon, MBA, Torreya Partners
- Neal G. Simon, PhD, Azevan Pharmaceuticals
- Barbara S. Slusher, PhD, MAS, Johns Hopkins University
- Deborah Somerville, Kenyon & Kenyon
- Mel Spigelman, MD, TB Alliance
- Mervyn J. Turner, PhD, MJTurner Consulting
- Gregory Wiederrecht, PhD, Merck
- Matthew A. Wikler, MD, The Medicines Company
|
